Evidence map›Paper›PMID 19491391›Full record

ArticleBlood2009

Graded repression of PU.1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate.

Stella T Chou, Eugene Khandros, L Charles Bailey, Kim E Nichols, Christopher R Vakoc, Yu Yao, Zan Huang, John D Crispino, Ross C Hardison, Gerd A Blobel and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 108 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. GATA1 in Normal and Pathologic Megakaryopoiesis and Platelet Development.Advances in experimental medicine and biology · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Stella T ChouDivision of Hematology, The Children's Hospital of Philadelphia, PA, USA.
Eugene Khandros
L Charles Bailey
Kim E Nichols
Christopher R Vakoc
Yu Yao
Zan Huang
John D Crispino
Ross C Hardison
Gerd A Blobel
Mitchell J Weiss
Children's Hospital of Philadelphia · USNorthwestern University · USCold Spring Harbor Laboratory · USPennsylvania State University · USUniversity of Pennsylvania · US

Funding

PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM008216 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI EPSTEIN, DOUGLAS J · 1987 to 2023
$8.3M
Mechanisms of Leukemogenesis in Down SyndromeR01CA101774 · NCI · UNIVERSITY OF CHICAGO · PI CRISPINO, JOHN D · 2003 to 2021
$6.1M
Global Predictions and Tests of Erythroid RegulationR01DK065806 · NIDDK · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI BLOBEL, GERD A, CHIAROMONTE, FRANCESCA · 2004 to 2013
$5.3M
Roles of CBP &PCAF During Hematopoietic DifferentiationR01DK058044 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI BLOBEL, GERD A · 2002 to 2023
$4.5M
Genetic modulators of erythro-megakaryocytic developmentK08HL093290 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI CHOU, STELLA T · 2008 to 2012
$670k
NCI NIH HHS R01 CA101774NHLBI NIH HHS K08 HL093290NIDDK NIH HHS R01 DK058044NIDDK NIH HHS R01 DK065806NIDDK NIH HHS R01DK065806NIDDK NIH HHS R01DK58044NIGMS NIH HHS T32 GM008216NIGMS NIH HHS T32 GM008216-22
6 · The paper itself

Abstract

GATA-1 and PU.1 are essential hematopoietic transcription factors that control erythromegakaryocytic and myelolymphoid differentiation, respectively. These proteins antagonize each other through direct physical interaction to repress alternate lineage programs. We used immortalized Gata1(-) erythromegakaryocytic progenitor cells to study how PU.1/Sfpi1 expression is regulated by GATA-1 and GATA-2, a related factor that is normally expressed at earlier stages of hematopoiesis. Both GATA factors bind the PU.1/Sfpi1 gene at 2 highly conserved regions. In the absence of GATA-1, GATA-2 binding is associated with an undifferentiated state, intermediate level PU.1/Sfpi1 expression, and low-level expression of its downstream myeloid target genes. Restoration of GATA-1 function induces erythromegakaryocytic differentiation. Concomitantly, GATA-1 replaces GATA-2 at the PU.1/Sfpi1 locus and PU.1/Sfpi1 expression is extinguished. In contrast, when GATA-1 is not present, shRNA knockdown of GATA-2 increases PU.1/Sfpi1 expression by 3-fold and reprograms the cells to become macrophages. Our findings indicate that GATA factors act sequentially to regulate lineage determination during hematopoiesis, in part by exerting variable repressive effects at the PU.1/Sfpi1 locus.

Indexed as

AnimalsCell LineageCells, CulturedCytokinesErythropoiesisGATA1 Transcription FactorGATA2 Transcription FactorGene Expression RegulationGene Knockdown TechniquesHematopoietic Stem CellsMacrophagesMiceProto-Oncogene ProteinsProto-Oncogene Protein Spi-1Recombinant Fusion ProteinsRepressor ProteinsCytokinesGata1 protein, mouseGATA1 Transcription FactorGata2 protein, mouseGATA2 Transcription FactorProto-Oncogene ProteinsProto-Oncogene Protein Spi-1Recombinant Fusion ProteinsRepressor ProteinsRNA, Small InterferingTrans-Activators

Identifiers

PMID19491391
PMCPMC2721792
OpenAlexW1975899374

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.